To confirm the results obtained in the PSGL-1 knockdown cells, we carried out a series of experiments using a pharmacological approach consisting in neutralizing PSGL-1 expressed on the surface of MM cells with a blocking antibody. The gene discussed is SELPLG; the disease is Miyoshi myopathy.